Ryan Gerbrandt's Net Worth

$2.55 Million

Estimate Recalculated Sep 16, 2024 08:41AM EST

Who is Ryan Gerbrandt?

Ryan Gerbrandt has an estimated net worth of $2.55 Million. This is based on reported shares in Anterix Inc..

SEC CIK

Ryan Gerbrandt's CIK is 0001821509

Past Insider Trading and Trends

2021 was Ryan Gerbrandt's most active year for acquiring shares with 2 total transactions. Ryan Gerbrandt's most active month to acquire stocks was the month of April. 2024 was Ryan Gerbrandt's most active year for disposing of shares, totalling 4 transactions. Ryan Gerbrandt's most active month to dispose stocks was the month of January. 2024 saw Ryan Gerbrandt paying a total of $0.00 for 60,000 shares, this is the most they've acquired in one year. In 2023 Ryan Gerbrandt cashed out on 6,767 shares for a total of $214,547.07, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Anterix Inc. (ATEX) Snapshot price: $36.3

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.98%
-1.48K
$41.51
-$61,393.29
48.09K
Jul 12
Form 4
-2.73%
-1.39K
$33.52
-$46,626.32
49.57K
May 17
Form 4
-5.33%
-2.87K
$32.72
-$93,808.24
50.96K
May 15
Form 4
—
0
—
—
0
Feb 28
Form 4
-4.36%
-2.46K
$37.76
-$92,738.56
53.83K
Feb 15
Form 4
+21.83%
10.09K
—
—
56.28K
Jul 12
Form 4
-8.48%
-4.28K
$31.11
-$133,213.02
46.2K
May 18
Form 4
-4.69%
-2.48K
$32.73
-$81,334.05
50.48K
Feb 15
Form 4
-3.06%
-1.67K
$54.10
-$90,563.40
52.96K
Scheduled
Feb 17
Form 4
-5.04%
-2.90K
$42.47
-$123,078.06
54.64K
May 27
Form 4
+28.20%
12.65K
—
—
57.54K
May 17
Form 4/A
+138.80%
26.09K
—
—
44.88K
May 5
Form 4
+138.80%
26.09K
—
—
44.88K
May 5
Form 4
-9.70%
-2.02K
$42.00
-$84,756.00
18.79K
Scheduled
Feb 17
Form 3
—
0
—
—
0
No matching records found